Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Let's get this pyrin started!

Emilia Liana Falcone1,2, Clare Bryant3

  • 1From the Microbiome and Mucosal Defense Research Unit, Montreal Clinical Research Institute (IRCM), Montréal, Quebec H2W 1R7, Canada, emilia.falcone@ircm.qc.ca.

The Journal of Biological Chemistry
|March 10, 2019
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Echocardiogram Testing in Patients with Post-COVID-19 Condition: A Systematic Review and Meta-Analysis.

Journal of clinical medicine·2026
Same author

Three Doses and Six Months Later: Real-World SARS-CoV-2 Specific Humoral and Cell-Mediated Immunity in Children With Inborn Errors of Immunity.

Journal of clinical immunology·2026
Same author

Toll-like receptor signaling outcome is determined by the stoichiometry of the endogenous TRIFosome.

Science advances·2026
Same author

Functional impact of long COVID among healthcare workers with comorbidities in Quebec, Canada: a cross-sectional study.

BMJ public health·2026
Same author

Case Report: Characterization of a RAC2 R68W homozygous activating mutation causing combined immune deficiency.

Frontiers in immunology·2026
Same author

Intestinal barrier compromise, viral persistence, and immune dysregulation converge on neurological sequelae in Long COVID.

Frontiers in aging neuroscience·2026

Researchers identified two microbiota-derived bile acid analogues, BAA485 and BAA473, as the first small molecules to activate the pyrin inflammasome, suggesting a link between gut microbes and inflammation.

Area of Science:

  • Immunology
  • Microbiology
  • Metabolomics

Background:

  • Inflammasomes are crucial immune sensors for detecting pathogens and cellular damage.
  • The precise signaling molecules that activate inflammasomes, particularly the pyrin inflammasome, remain incompletely understood.
  • The gut microbiota's role in modulating host immunity is increasingly recognized.

Purpose of the Study:

  • To identify microbial metabolites capable of activating the pyrin inflammasome.
  • To investigate the potential role of microbiota-derived compounds in regulating inflammatory responses.
  • To explore the contribution of these metabolites to maintaining intestinal homeostasis.

Main Methods:

  • Utilized biochemical assays to screen for inflammasome-activating small molecules.

Related Experiment Videos

  • Investigated the effects of specific bile acid analogues on pyrin inflammasome activation.
  • Employed cell-based models to assess the impact of identified metabolites on inflammatory pathways.

    • Main Results:

    • Identified two novel bile acid analogues, BAA485 and BAA473, derived from gut microbiota.
    • Demonstrated that BAA485 and BAA473 are the first identified small molecules to directly activate the pyrin inflammasome.
    • These findings establish a direct molecular link between specific microbial metabolites and inflammasome activation.

    Conclusions:

    • Microbiota-derived metabolites, specifically BAA485 and BAA473, can directly activate the pyrin inflammasome.
    • This discovery suggests a mechanism by which the gut microbiota can modulate host inflammatory processes.
    • These findings have implications for understanding and potentially manipulating intestinal homeostasis through microbial metabolites.